EX
eXoZymes, Inc.
EXOZ · NASDAQ
$6.14 -11.84% (-$0.83)
1M -11.65%
Market Cap $57.0M
P/E Ratio -
Div. Yield -
ROE 292.13%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 15.60x
EV/FFO N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 35.27%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 292.13%
ROA 127.67%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 3.81x
Debt/Equity 0.20x
Net debt/EBITDA N/A
Stability
1 /100
Unstable EPS volatility 80.15%
Profitable years 0
Beta 3.15x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EXOZ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael Heltzen
Employees
32
Headquarters
Monrovia